Measurement of colony-stimulating factors in synovial fluid : potential clinical value
In this study, 100 synovial fluid (SF) samples from patients with a variety of arthritides were assayed for levels of colony-stimulating factors (CSFs) using a human bone-marrow bioassay and enzyme immunoassays for granulocyte (G-) and granulocyte-macrophage (GM-) CSFs. GM-CSF was found more frequen...
Gespeichert in:
Veröffentlicht in: | Rheumatology international 1995, Vol.14 (5), p.177-182 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 182 |
---|---|
container_issue | 5 |
container_start_page | 177 |
container_title | Rheumatology international |
container_volume | 14 |
creator | BELL, A. L MAGILL, M. K MCKANE, W. R KIRK, F IRVINE, A. E |
description | In this study, 100 synovial fluid (SF) samples from patients with a variety of arthritides were assayed for levels of colony-stimulating factors (CSFs) using a human bone-marrow bioassay and enzyme immunoassays for granulocyte (G-) and granulocyte-macrophage (GM-) CSFs. GM-CSF was found more frequently in samples from rheumatoid arthritis (RA) subjects (49%) than in non-RA samples (29%). Absence of GM- but not G- or bioassay CSFs characterised samples from subjects with psoriatic arthritis and ankylosing spondylitis (n = 14). There was strong evidence of an antagonistic relationship between levels of G- and GM-CSFs in samples from RA patients, an effect independent of drug treatment. However, treatment with non-steroidal anti-inflammatory agents (NSAIDs) may affect reported CSF concentrations: G-CSF levels were significantly lower in samples from subjects not taking NSAIDs. These results suggest that SF-CSF estimations using commercially available assays could provide useful diagnostic clues for clinicians, but careful interpretation is warranted particularly in patients on long-term NSAID treatment. |
doi_str_mv | 10.1007/BF00262295 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77228008</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77228008</sourcerecordid><originalsourceid>FETCH-LOGICAL-c311t-c0b492834c3407bfb23d9b7ff0b69e5834c8f031a89a25b46e89d7bb9e4088f93</originalsourceid><addsrcrecordid>eNpFkM9LwzAUx4Moc04v3oUexINQfUnaJvGmw6kw8aLirSRpIpG0mU072H9vx8q8vF_fz3vwvgidY7jBAOz2YQFACkJEfoCmOKMsxQV8HaIpYEZSPoRjdBLjDwx9UcAETVhOC5HTKfp8NTL2ralN0yXBJjr40GzS2Lm697JzzXdipe5CGxPXJHHThLWTPrG-d1Vyl6xCNyxuJ9q7xumhWEvfm1N0ZKWP5mzMM_SxeHyfP6fLt6eX-f0y1RTjLtWgMkE4zTTNgCmrCK2EYtaCKoTJtwK3QLHkQpJcZYXhomJKCZMB51bQGbra3V214bc3sStrF7XxXjYm9LFkjBAOwAfwegfqNsTYGluuWlfLdlNiKLcmlv8mDvDFeLVXtan26OjaoF-OuozDy7aVjXZxj1HKs4wC_QO-bHkx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77228008</pqid></control><display><type>article</type><title>Measurement of colony-stimulating factors in synovial fluid : potential clinical value</title><source>MEDLINE</source><source>Springer Online Journals Complete</source><creator>BELL, A. L ; MAGILL, M. K ; MCKANE, W. R ; KIRK, F ; IRVINE, A. E</creator><creatorcontrib>BELL, A. L ; MAGILL, M. K ; MCKANE, W. R ; KIRK, F ; IRVINE, A. E</creatorcontrib><description>In this study, 100 synovial fluid (SF) samples from patients with a variety of arthritides were assayed for levels of colony-stimulating factors (CSFs) using a human bone-marrow bioassay and enzyme immunoassays for granulocyte (G-) and granulocyte-macrophage (GM-) CSFs. GM-CSF was found more frequently in samples from rheumatoid arthritis (RA) subjects (49%) than in non-RA samples (29%). Absence of GM- but not G- or bioassay CSFs characterised samples from subjects with psoriatic arthritis and ankylosing spondylitis (n = 14). There was strong evidence of an antagonistic relationship between levels of G- and GM-CSFs in samples from RA patients, an effect independent of drug treatment. However, treatment with non-steroidal anti-inflammatory agents (NSAIDs) may affect reported CSF concentrations: G-CSF levels were significantly lower in samples from subjects not taking NSAIDs. These results suggest that SF-CSF estimations using commercially available assays could provide useful diagnostic clues for clinicians, but careful interpretation is warranted particularly in patients on long-term NSAID treatment.</description><identifier>ISSN: 0172-8172</identifier><identifier>EISSN: 1437-160X</identifier><identifier>DOI: 10.1007/BF00262295</identifier><identifier>PMID: 7536953</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Arthritis, Rheumatoid - metabolism ; Biological and medical sciences ; Biomarkers ; Diseases of the osteoarticular system ; Granulocyte Colony-Stimulating Factor - analysis ; Granulocyte-Macrophage Colony-Stimulating Factor - analysis ; Humans ; Inflammatory joint diseases ; Medical sciences ; Synovial Fluid - metabolism</subject><ispartof>Rheumatology international, 1995, Vol.14 (5), p.177-182</ispartof><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c311t-c0b492834c3407bfb23d9b7ff0b69e5834c8f031a89a25b46e89d7bb9e4088f93</citedby><cites>FETCH-LOGICAL-c311t-c0b492834c3407bfb23d9b7ff0b69e5834c8f031a89a25b46e89d7bb9e4088f93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4022,27922,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3384430$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7536953$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BELL, A. L</creatorcontrib><creatorcontrib>MAGILL, M. K</creatorcontrib><creatorcontrib>MCKANE, W. R</creatorcontrib><creatorcontrib>KIRK, F</creatorcontrib><creatorcontrib>IRVINE, A. E</creatorcontrib><title>Measurement of colony-stimulating factors in synovial fluid : potential clinical value</title><title>Rheumatology international</title><addtitle>Rheumatol Int</addtitle><description>In this study, 100 synovial fluid (SF) samples from patients with a variety of arthritides were assayed for levels of colony-stimulating factors (CSFs) using a human bone-marrow bioassay and enzyme immunoassays for granulocyte (G-) and granulocyte-macrophage (GM-) CSFs. GM-CSF was found more frequently in samples from rheumatoid arthritis (RA) subjects (49%) than in non-RA samples (29%). Absence of GM- but not G- or bioassay CSFs characterised samples from subjects with psoriatic arthritis and ankylosing spondylitis (n = 14). There was strong evidence of an antagonistic relationship between levels of G- and GM-CSFs in samples from RA patients, an effect independent of drug treatment. However, treatment with non-steroidal anti-inflammatory agents (NSAIDs) may affect reported CSF concentrations: G-CSF levels were significantly lower in samples from subjects not taking NSAIDs. These results suggest that SF-CSF estimations using commercially available assays could provide useful diagnostic clues for clinicians, but careful interpretation is warranted particularly in patients on long-term NSAID treatment.</description><subject>Arthritis, Rheumatoid - metabolism</subject><subject>Biological and medical sciences</subject><subject>Biomarkers</subject><subject>Diseases of the osteoarticular system</subject><subject>Granulocyte Colony-Stimulating Factor - analysis</subject><subject>Granulocyte-Macrophage Colony-Stimulating Factor - analysis</subject><subject>Humans</subject><subject>Inflammatory joint diseases</subject><subject>Medical sciences</subject><subject>Synovial Fluid - metabolism</subject><issn>0172-8172</issn><issn>1437-160X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkM9LwzAUx4Moc04v3oUexINQfUnaJvGmw6kw8aLirSRpIpG0mU072H9vx8q8vF_fz3vwvgidY7jBAOz2YQFACkJEfoCmOKMsxQV8HaIpYEZSPoRjdBLjDwx9UcAETVhOC5HTKfp8NTL2ralN0yXBJjr40GzS2Lm697JzzXdipe5CGxPXJHHThLWTPrG-d1Vyl6xCNyxuJ9q7xumhWEvfm1N0ZKWP5mzMM_SxeHyfP6fLt6eX-f0y1RTjLtWgMkE4zTTNgCmrCK2EYtaCKoTJtwK3QLHkQpJcZYXhomJKCZMB51bQGbra3V214bc3sStrF7XxXjYm9LFkjBAOwAfwegfqNsTYGluuWlfLdlNiKLcmlv8mDvDFeLVXtan26OjaoF-OuozDy7aVjXZxj1HKs4wC_QO-bHkx</recordid><startdate>1995</startdate><enddate>1995</enddate><creator>BELL, A. L</creator><creator>MAGILL, M. K</creator><creator>MCKANE, W. R</creator><creator>KIRK, F</creator><creator>IRVINE, A. E</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1995</creationdate><title>Measurement of colony-stimulating factors in synovial fluid : potential clinical value</title><author>BELL, A. L ; MAGILL, M. K ; MCKANE, W. R ; KIRK, F ; IRVINE, A. E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c311t-c0b492834c3407bfb23d9b7ff0b69e5834c8f031a89a25b46e89d7bb9e4088f93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Arthritis, Rheumatoid - metabolism</topic><topic>Biological and medical sciences</topic><topic>Biomarkers</topic><topic>Diseases of the osteoarticular system</topic><topic>Granulocyte Colony-Stimulating Factor - analysis</topic><topic>Granulocyte-Macrophage Colony-Stimulating Factor - analysis</topic><topic>Humans</topic><topic>Inflammatory joint diseases</topic><topic>Medical sciences</topic><topic>Synovial Fluid - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BELL, A. L</creatorcontrib><creatorcontrib>MAGILL, M. K</creatorcontrib><creatorcontrib>MCKANE, W. R</creatorcontrib><creatorcontrib>KIRK, F</creatorcontrib><creatorcontrib>IRVINE, A. E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Rheumatology international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BELL, A. L</au><au>MAGILL, M. K</au><au>MCKANE, W. R</au><au>KIRK, F</au><au>IRVINE, A. E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Measurement of colony-stimulating factors in synovial fluid : potential clinical value</atitle><jtitle>Rheumatology international</jtitle><addtitle>Rheumatol Int</addtitle><date>1995</date><risdate>1995</risdate><volume>14</volume><issue>5</issue><spage>177</spage><epage>182</epage><pages>177-182</pages><issn>0172-8172</issn><eissn>1437-160X</eissn><abstract>In this study, 100 synovial fluid (SF) samples from patients with a variety of arthritides were assayed for levels of colony-stimulating factors (CSFs) using a human bone-marrow bioassay and enzyme immunoassays for granulocyte (G-) and granulocyte-macrophage (GM-) CSFs. GM-CSF was found more frequently in samples from rheumatoid arthritis (RA) subjects (49%) than in non-RA samples (29%). Absence of GM- but not G- or bioassay CSFs characterised samples from subjects with psoriatic arthritis and ankylosing spondylitis (n = 14). There was strong evidence of an antagonistic relationship between levels of G- and GM-CSFs in samples from RA patients, an effect independent of drug treatment. However, treatment with non-steroidal anti-inflammatory agents (NSAIDs) may affect reported CSF concentrations: G-CSF levels were significantly lower in samples from subjects not taking NSAIDs. These results suggest that SF-CSF estimations using commercially available assays could provide useful diagnostic clues for clinicians, but careful interpretation is warranted particularly in patients on long-term NSAID treatment.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>7536953</pmid><doi>10.1007/BF00262295</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0172-8172 |
ispartof | Rheumatology international, 1995, Vol.14 (5), p.177-182 |
issn | 0172-8172 1437-160X |
language | eng |
recordid | cdi_proquest_miscellaneous_77228008 |
source | MEDLINE; Springer Online Journals Complete |
subjects | Arthritis, Rheumatoid - metabolism Biological and medical sciences Biomarkers Diseases of the osteoarticular system Granulocyte Colony-Stimulating Factor - analysis Granulocyte-Macrophage Colony-Stimulating Factor - analysis Humans Inflammatory joint diseases Medical sciences Synovial Fluid - metabolism |
title | Measurement of colony-stimulating factors in synovial fluid : potential clinical value |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T16%3A46%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Measurement%20of%20colony-stimulating%20factors%20in%20synovial%20fluid%20:%20potential%20clinical%20value&rft.jtitle=Rheumatology%20international&rft.au=BELL,%20A.%20L&rft.date=1995&rft.volume=14&rft.issue=5&rft.spage=177&rft.epage=182&rft.pages=177-182&rft.issn=0172-8172&rft.eissn=1437-160X&rft_id=info:doi/10.1007/BF00262295&rft_dat=%3Cproquest_cross%3E77228008%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77228008&rft_id=info:pmid/7536953&rfr_iscdi=true |